Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q4 2025 Earnings Call Transcript February 24, 2026
Operator: Good afternoon, and welcome to Tarsus Fourth Quarter and Full Year 2025 Financial Results Conference Call. As a reminder, this call is being recorded. [Operator Instructions]. At this time, I would like to turn the call over to David Nakasone, Head of Investor Relations, to lead off the call. David, you may begin.
David Nakasone: Thank you. Before we begin, I encourage everyone to visit...
